10-15 Associates’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

10-15 Associates’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,670	Closed	-$205K	–	101
2020 Q2	$205K	Buy	+1,670	New	+$189K	0.04%	90
2019 Q3	–	Sell	-1,670	Closed	-$288K	–	103
2019 Q2	$288K	Buy	1,670 +30	+2%	+$5.19K	0.06%	89
2019 Q1	$276K	Buy	+1,640	New	+$244K	0.06%	90
2018 Q4	–	Sell	-1,440	Closed	-$249K	–	102
2018 Q3	$249K	Sell	1,440 -195	-12%	-$28.1K	0.06%	92
2018 Q2	$228K	Buy	+1,635	New	+$232K	0.05%	104

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

10-15 Associates's GWPH Position: Q3 2020 in Review

10-15 Associates sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2020, closing a stake of 1,670 shares — an estimated $205K sold.

10-15 Associates first reported a position in GWPH in Q2 2018 and held it in 5 quarters. The position peaked at $288K in Q2 2019. 279 funds tracked by Wall St. Rank hold GWPH as of Q3 2020.

10-15 Associates reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q3 2020 after selling out during the quarter.
10-15 Associates sold 1,670 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2020, an estimated $205K.
10-15 Associates first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2018 and held it in 5 quarters.
10-15 Associates's GW Pharmaceuticals Plc American Depositary Shares position peaked at $288K in Q2 2019.
279 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2020.

Based on 10-15 Associates's 13F filing for Q3 2020, filed 13 Oct 2020.